IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 441 - 452 of 1451 stories.
February 12, 2014
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI), a contract development and manufacturing organization specializing in small molecule active pharmaceutical ingredients (APIs), says...
February 12, 2014
The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the company’s fiscal third quarter, ended 31 December...
February 11, 2014
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 29% fall in sales in the company’s fiscal third...
February 11, 2014
Cambrex (East Rutherford, NJ) reports a 79.6% fall in net profits for the fourth quarter of 2013, ended 31 December, compared with the year-ago quarter, to $8.89 million. The results...
February 11, 2014
Jazz Pharmaceuticals (Dublin), a specialty biopharmaceutical company, on Monday held a ground breaking ceremony for a €45–50 million ($60-68 million) manufacturing and...
February 11, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in...
February 7, 2014
The active pharmaceutical ingredient (API) business of Ranbaxy Laboratories (Gurgaon, India) reports sales of 1.37 billion Indian rupees ($22 million) in the fourth quarter of 2013...
February 7, 2014
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in sales in the fourth quarter of 2013, compared with...
February 5, 2014
FMC today reported fourth-quarter earnings down 73.5% year-on-year (YOY), to $27.1 million, or 20 cts/share, on sales up 24%, to $1.1 billion. Earnings were hit by $114.3 million in...
February 4, 2014
Johnson Matthey appoints new CEO, fine chemicals sales up Johnson Matthey announced the appointment of its new CEO and reported the third-quarter results, covering 1 October 2013...
January 28, 2014
Albemarle today reported fourth-quarter adjusted earnings of $88.4 million, or $1.08/share, down 16% year-on-year (YOY), but ahead of analysts' consensus estimate of $1.04/share as...
January 28, 2014
Informex 2014: Rising certainty despite challenges for pharma Attendees and exhibitors at this year's Informex USA, held last week in Miami Beach, were mostly optimistic about the...
Pages: « Previous  36 37 38 39 40 41 42 43 44 [45] 46 47 48 49 50 51 52 53 54 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa